The results showed that ZSCAN20 expressed significantly different in various HCC samples, gender, age, cancer stages, tumor grade, nodal metastasis status, histological subtypes (Figure 2A–2G). This evidence concerns the gene ZSCAN20 and hepatocellular carcinoma.